ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Bajaj Healthcare Limited concluded its 33rd Annual General Meeting on September 21, 2026. The shareholders transacted ordinary and special business, including a final dividend declaration.
Bajaj Healthcare Limited has fixed September 14, 2026, as the record date for a 30% final dividend. The dividend of ₹1.50 per share awaits shareholder approval.
Q1FY27 revenue grew 11.3% YoY to INR 165.6 Cr with PAT at INR 13.9 Cr. Focus shifting toward high-margin peptides, oncology APIs, and specialized formulations.
Bajaj Healthcare is pivoting from high-volume commodities to high-margin specialized APIs and formulations, targeting a ₹1000 Cr topline via new oncology and peptide capacities.
Bajaj Healthcare Ltd reported revenue from operations of ₹165.6 Cr (+11.3% YoY) and net profit of ₹13.7 Cr (+16.1% YoY) for Q1 FY27.
Bajaj Healthcare Ltd reported revenue from operations of ₹153.1 Cr (-0.9% YoY) and a net loss of ₹22.9 Cr for Q4 FY26.